Cargando…

Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses

Antitumor immunity can be enhanced by the coordinated release and delivery of antigens and immune-stimulating agents to antigen-presenting cells via biodegradable vaccine carriers. So far, encapsulation of TLR ligands and tumor-associated antigens augmented cytotoxic T cell (CTLs) responses. Here, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dölen, Yusuf, Kreutz, Martin, Gileadi, Uzi, Tel, Jurjen, Vasaturo, Angela, van Dinther, Eric A. W., van Hout-Kuijer, Maaike A., Cerundolo, Vincenzo, Figdor, Carl G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760331/ https://www.ncbi.nlm.nih.gov/pubmed/26942088 http://dx.doi.org/10.1080/2162402X.2015.1068493

Ejemplares similares

Nanovaccine administration route is critical to obtain pertinent iNKt cell help for robust anti-tumor T and B cell responses
por: Dölen, Yusuf, et al.
Publicado: (2020)

PLGA Nanoparticles Co-encapsulating NY-ESO-1 Peptides and IMM60 Induce Robust CD8 and CD4 T Cell and B Cell Responses
por: Dölen, Yusuf, et al.
Publicado: (2021)

Microfluidics-Assisted Size Tuning and Biological Evaluation of PLGA Particles
por: Operti, Maria Camilla, et al.
Publicado: (2019)

Non‐glycosidic compounds can stimulate both human and mouse iNKT cells
por: Jukes, John‐Paul, et al.
Publicado: (2016)

CD169(+) MACROPHAGES PRESENT LIPID ANTIGENS TO MEDIATE EARLY ACTIVATION OF INVARIANT NKT CELLS IN LYMPH NODES
por: Barral, Patricia, et al.
Publicado: (2010)

Invariant NKT cells modulate the suppressive activity of Serum Amyloid A-differentiated IL-10-secreting neutrophils
por: De Santo, Carmela, et al.
Publicado: (2010)

Intracellular Bacterial Infection and Invariant NKT Cells
por: Emoto, Masashi, et al.
Publicado: (2009)

Exploiting Antitumor Immunotherapeutic Novel Strategies by Deciphering the Cross Talk between Invariant NKT Cells and Dendritic Cells
por: Fujii, Shin-ichiro, et al.
Publicado: (2017)

Invariant NKT cells dictate antitumor immunity elicited by a bispecific antibody cotargeting CD3 and BCMA
por: Casey, Mika, et al.
Publicado: (2022)

Injectable Biomimetic Hydrogels as Tools for Efficient T Cell Expansion and Delivery
por: Weiden, Jorieke, et al.
Publicado: (2018)

Invariant NKT cells: Killers and conspirators against cancer
por: Bassiri, Hamid, et al.
Publicado: (2013)

Improved Detection of Cytokines Produced by Invariant NKT Cells
por: Sag, Duygu, et al.
Publicado: (2017)

Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells
por: Salio, Mariolina, et al.
Publicado: (2017)

PEG–PLGA nanoparticles for encapsulating ciprofloxacin
por: Watcharadulyarat, Natsorn, et al.
Publicado: (2023)

Activation of Invariant NKT Cells Exacerbates Experimental Visceral Leishmaniasis
por: Stanley, Amanda C., et al.
Publicado: (2008)

Invariant NKT Cells: Regulation and Function during Viral Infection
por: Juno, Jennifer A., et al.
Publicado: (2012)

Invariant NKT Cell Response to Dengue Virus Infection in Human
por: Matangkasombut, Ponpan, et al.
Publicado: (2014)

Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors
por: Pilones, Karsten A., et al.
Publicado: (2012)

Effects of Invariant NKT Cells on Parasite Infections and Hygiene Hypothesis
por: Yang, Jun-Qi, et al.
Publicado: (2016)

Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy
por: Wolf, Benjamin J., et al.
Publicado: (2018)

Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells
por: Eggermont, Loek J., et al.
Publicado: (2014)

The Response of CD1d-Restricted Invariant NKT Cells to Microbial Pathogens and Their Products
por: Van Kaer, Luc, et al.
Publicado: (2015)

Mouse Invariant Monoclonal Antibody NKT14: A Novel Tool to Manipulate iNKT Cell Function In Vivo
por: Scheuplein, Felix, et al.
Publicado: (2015)

A Dominant Role for the Immunoproteasome in CD8(+) T Cell Responses to Murine Cytomegalovirus
por: Hutchinson, Sarah, et al.
Publicado: (2011)

Invariant NKT Cells as Initiators, Licensors, and Facilitators of the Adaptive Immune Response
por: Stein-Streilein, Joan
Publicado: (2003)

Invariant NKT cells are required for airway inflammation induced by environmental antigens
por: Wingender, Gerhard, et al.
Publicado: (2011)

Exploiting invariant NKT cells to promote T-cell responses to cancer vaccines
por: Hunn, Martin K., et al.
Publicado: (2013)

Eomes transcription factor is required for the development and differentiation of invariant NKT cells
por: Shimizu, Kanako, et al.
Publicado: (2019)

TIM-4 is expressed on invariant NKT cells but dispensable for their development and function
por: Zhang, Xilin, et al.
Publicado: (2016)

Invariant NKT Cells and Rheumatic Disease: Focus on Primary Sjogren Syndrome
por: Rizzo, Chiara, et al.
Publicado: (2019)

Invariant NKT cells metabolically adapt to the acute myeloid leukaemia environment
por: Stavrou, Victoria, et al.
Publicado: (2022)

Robust Antigen-Specific T Cell Activation within Injectable 3D Synthetic Nanovaccine Depots
por: Weiden, Jorieke, et al.
Publicado: (2021)

The location of splenic NKT cells favours their rapid activation by blood-borne antigen
por: Barral, Patricia, et al.
Publicado: (2012)

Assessing the safety, tolerability and efficacy of PLGA-based immunomodulatory nanoparticles in patients with advanced NY-ESO-1-positive cancers: a first-in-human phase I open-label dose-escalation study protocol
por: Creemers, Jeroen H A, et al.
Publicado: (2021)

Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses
por: Fujii, Shin-ichiro, et al.
Publicado: (2018)

Naturally circulating dendritic cells to vaccinate cancer patients
por: Bol, Kalijn F., et al.
Publicado: (2013)

Hiding Lipid Presentation: Viral Interference with CD1d-Restricted Invariant Natural Killer T (iNKT) Cell Activation
por: Horst, Daniëlle, et al.
Publicado: (2012)

Harnessing human plasmacytoid dendritic cells as professional APCs
por: Tel, Jurjen, et al.
Publicado: (2012)

Differential antitumor immunity mediated by NKT cell subsets in vivo
por: Crowe, Nadine Y., et al.
Publicado: (2005)

Invariant NKT cells recognize glycolipids from pathogenic Gram-positive bacteria
por: Kinjo, Yuki, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_0o2tic1hg7i055pq788gsavdv4